Scientists test new mRNA shots in quest for HIV vaccine
NCT ID NCT06557785
Summary
This is an early-stage safety study testing two experimental mRNA vaccines designed to train the immune system against HIV. The trial will enroll 53 healthy adults without HIV to check if the vaccines are safe and can trigger an immune response. This is a first-in-human study, meaning it's the first time these specific vaccines are being tested in people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center (Site ID: 32077)
Boston, Massachusetts, 02215, United States
-
Columbia P&S (Site ID: 30329)
New York, New York, 10032, United States
-
New York Blood Center (Site ID: 31801)
New York, New York, 10065, United States
-
Penn Prevention (Site ID: 30310)
Philadelphia, Pennsylvania, 19104, United States
-
Seattle Vaccine and Prevention (Site ID: 30331)
Seattle, Washington, 98104, United States
-
University of Pittsburgh (Site ID: 1001)
Pittsburgh, Pennsylvania, 15213, United States
-
Vaccine Trial Centre, Mahidol University CRS (Site ID: 32021)
Bangkok, Ratchathewi, 10400, Thailand
Conditions
Explore the condition pages connected to this study.